Growth Metrics

INSMED (INSM) EBIT: 2010-2014

Historic EBIT for INSMED (INSM) over the last 3 years, with Jun 2014 value amounting to -$22.8 million.

  • INSMED's EBIT fell 175.92% to -$22.8 million in Q2 2014 from the same period last year, while for Jun 2014 it was -$73.3 million, marking a year-over-year decrease of 74.96%. This contributed to the annual value of -$55.0 million for FY2013, which is 29.64% down from last year.
  • According to the latest figures from Q2 2014, INSMED's EBIT is -$22.8 million, which was down 26.20% from -$18.1 million recorded in Q1 2014.
  • Over the past 5 years, INSMED's EBIT peaked at $1.8 million during Q4 2010, and registered a low of -$22.8 million during Q2 2014.
  • For the 3-year period, INSMED's EBIT averaged around -$13.6 million, with its median value being -$14.3 million (2013).
  • In the last 5 years, INSMED's EBIT increased by 17.17% in 2013 and then slumped by 175.92% in 2014.
  • INSMED's EBIT (Quarterly) stood at $1.8 million in 2010, then reached -$9.4 million in 2012, then tumbled by 80.07% to -$15.6 million in 2013, then slumped by 175.92% to -$22.8 million in 2014.
  • Its EBIT was -$22.8 million in Q2 2014, compared to -$18.1 million in Q1 2014 and -$15.6 million in Q4 2013.